Abstract
The 2nd Annual Current Trends in Pediatric Dermatology Series was held in New York City (NY, USA) on November 8, 2009. With an attendance of over 150 people, this event brought together prominent guest speakers from multiple disciplines, including pediatrics, dermatology and endocrinology. This continuing medical education series addressed a number of common clinical scenarios within the realm of pediatric dermatology, and also reviewed current and newly developed therapeutic options. This lecture series contained many clinical pearls, useful for both full practicing physicians, as well as residents. This review contains an overview of some of the salient issues discussed at the meeting.
Financial & competing interests disclosure
Andrew Alexis has served on the speaker’s bureau for Amgen, Galderma, Medicis and Sanofi-Aventis, has received honoraria from Abbot (for a speaking engagement) and acted on the advisory board for Galderma and Stiefel, a GSK company. Nanette B Silverberg has acted as a speaker for Stiefel, has received honoraria from Johnson&Johnson, and acted as an investigator for Astellas and Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.